I don't think they are big ripples
This company, today, has a market cap of $9.4M
It has $3.5M cash. Therefore the value placed on the balance of the company is $5.9M
Epichem is cashflow positive this quarter and is expected (as detailed in company announcements) to ramp up sales 3 fold to $10M by 2020. Query whether these figures are conservative though as Epichem has just increased its lab space by 50%.
This in itself could arguably justify a much higher share price than current.
Then... well there are Phase 2 trials with a drug that has a proven safety profile... and an option agreement with a medical giant. Value - zip.
I don't think they are big ripples :) This company, today, has a...
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |